Related Experiment Video
Updated: Sep 21, 2026
Implantation of the Syncardia Total Artificial Heart
Published on: July 17, 2014
The effect of modified ultrafiltration on the postoperative course in patients with congenital heart disease
1Division of Cardiothoracic Surgery, The Cardiac Center at The Children's Hospital of Philadelphia, PA 19104-4399, USA. gaynor@email.chop.edu
Insights
Modified ultrafiltration (MUF) after cardiopulmonary bypass improves infant outcomes for congenital heart defect repair by reducing fluid overload and inflammation. This technique enhances recovery, decreasing ventilation time and improving cardiac function.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Critical Care Medicine
Background:
- Cardiopulmonary bypass (CPB) for congenital heart defect repair reduces morbidity but causes hemodilution, hyperthermia, and systemic inflammation.
- CPB-induced inflammation can lead to organ dysfunction, particularly affecting the heart, lungs, and brain in infants.
- Modified ultrafiltration (MUF) was developed to mitigate CPB-related complications.
Purpose of the Study:
- To evaluate the effects of modified ultrafiltration (MUF) on organ function and postoperative morbidity in infants undergoing congenital heart defect repair.
- To investigate the benefits of MUF in reversing CPB-induced hemodilution and tissue edema.
Main Methods:
- Review of studies evaluating modified ultrafiltration (MUF) use following cardiopulmonary bypass (CPB) in pediatric cardiac surgery.
- Analysis of MUF's impact on fluid balance, inflammation markers, and organ function post-CPB.
Main Results:
- MUF effectively reverses hemodilution and reduces tissue edema, leading to improved pulmonary function and decreased need for postoperative ventilation.
- MUF enhances left ventricular function, reduces postoperative bleeding, and lowers the incidence and duration of pleural effusions, especially after the Fontan procedure.
- Evidence suggests MUF significantly reduces postoperative morbidity in infants undergoing congenital heart defect repair.
Conclusions:
- Modified ultrafiltration is a valuable technique for improving outcomes after cardiopulmonary bypass in pediatric cardiac surgery.
- Further research is needed to elucidate the precise mechanisms of MUF's benefits and to establish optimal patient selection and protocols.
- Future prospective randomized trials are essential to define the ideal utilization of ultrafiltration during and after CPB.
Abstract:
Improvements in the technology of cardiopulmonary bypass have significantly reduced morbidity following repair of congenital cardiac defects. However, the use of cardiopulmonary bypass exposes infants to extremes of hemodilution and hyperthermia, often in association with tissue ischemia. Exposure of the blood to surfaces of the bypass circuit initiates a systemic inflammatory response that may result in organ dysfunction after cardiopulmonary bypass, especially the heart, lungs, and brain. The technique of modified ultrafiltration (MUF) was introduced by Naik and colleagues at the Hospital for Sick Children in London over 10 years ago. Since that time, multiple studies have evaluated the effects of MUF on organ function and postoperative morbidity following repair of congenital heart defects. Use of MUF after cardiopulmonary bypass reverses hemodilution and decreases tissue edema resulting in improved pulmonary function with decreased duration of postoperative ventilation, improved left ventricular function, decreased postoperative bleeding, and a decrease in the incidence and duration of pleural effusions following the Fontan procedure. Despite the increasing evidence that the use of MUF reduces postoperative morbidity, many important questions remain unresolved. The mechanisms by which MUF results in these beneficial effects requires additional investigation. In addition, further studies are necessary to identify patients most likely to benefit from MUF and to define the optimal protocols for its use. In the future, prospective randomized studies incorporating recent advances in the technology of cardiopulmonary bypass will be necessary to define the optimal utilization of ultrafiltration during and after cardiopulmonary bypass.
Related Concept Videos
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
01:28Mitral Regurgitation IV: Nursing Management
01:30Heart Failure V: Medical Management
01:22Heart Failure VI: Adjunct Therapies
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
01:30Continuous Renal Replacement Therapy